0 Comments
0 Shares
183 Views
0 Reviews
Search
Discover new people, create new connections and make new friends
-
Please log in to like, share and comment!
-
Increasing Antimicrobial Resistance Accelerates Research and Investment in the Antimicrobial Peptides Market"Executive Summary Antimicrobial Peptides Market Trends: Share, Size, and Future Forecast CAGR Value Global antimicrobial peptides market size was valued at USD 5.92 billion in 2024 and is projected to reach USD 9.30 billion by 2032, with a CAGR of 5.80% during the forecast period of 2025 to 2032. Being an excellent market research report, Antimicrobial Peptides Market report...0 Comments 0 Shares 463 Views 0 Reviews
-
Ceftazidime Avibactam Market Growth & CAGR 9.7% ForecastAccording to a newly published market research report by 24LifeSciences, global Ceftazidime Avibactam market was valued at USD 1.2 billion in 2025 and is projected to reach USD 2.8 billion by 2034, growing at a compound annual growth rate (CAGR) of 9.7% during the forecast period 20262034. Ceftazidime Avibactam is a fixed-dose combination antibiotic incorporating ceftazidime (3rd...0 Comments 0 Shares 55 Views 0 Reviews
-
Ceftazidime Avibactam Market Growth & CAGR 9.7% ForecastAccording to a newly published market research report by 24LifeSciences, global Ceftazidime Avibactam market was valued at USD 1.2 billion in 2025 and is projected to reach USD 2.8 billion by 2034, growing at a compound annual growth rate (CAGR) of 9.7% during the forecast period 20262034. Ceftazidime Avibactam is a fixed-dose combination antibiotic incorporating ceftazidime (3rd...0 Comments 0 Shares 41 Views 0 Reviews
-
Ceftazidime Avibactam Market Growth & CAGR 9.7% ForecastAccording to a newly published market research report by 24LifeSciences, global Ceftazidime Avibactam market was valued at USD 1.2 billion in 2025 and is projected to reach USD 2.8 billion by 2034, growing at a compound annual growth rate (CAGR) of 9.7% during the forecast period 20262034. Ceftazidime Avibactam is a fixed-dose combination antibiotic incorporating ceftazidime (3rd...0 Comments 0 Shares 43 Views 0 Reviews
-
Global Ceftazidime Avibactam Market Insights & Growth Trends | CAGR 9.7% (2026–2034)According to a newly published market research report by 24LifeSciences, global Ceftazidime Avibactam market was valued at USD 1.2 billion in 2025 and is projected to reach USD 2.8 billion by 2034, growing at a compound annual growth rate (CAGR) of 9.7% during the forecast period 20262034. Ceftazidime Avibactam is a fixed-dose combination antibiotic incorporating ceftazidime (3rd...0 Comments 0 Shares 76 Views 0 Reviews
-
Global Ceftazidime Avibactam Market Insights & Growth Trends | CAGR 9.7% (2026–2034)According to a newly published market research report by 24LifeSciences, global Ceftazidime Avibactam market was valued at USD 1.2 billion in 2025 and is projected to reach USD 2.8 billion by 2034, growing at a compound annual growth rate (CAGR) of 9.7% during the forecast period 20262034. Ceftazidime Avibactam is a fixed-dose combination antibiotic incorporating ceftazidime (3rd...0 Comments 0 Shares 60 Views 0 Reviews
-
Global Ceftazidime Avibactam Market Insights & Growth Trends | CAGR 9.7% (2026–2034)According to a newly published market research report by 24LifeSciences, global Ceftazidime Avibactam market was valued at USD 1.2 billion in 2025 and is projected to reach USD 2.8 billion by 2034, growing at a compound annual growth rate (CAGR) of 9.7% during the forecast period 20262034. Ceftazidime Avibactam is a fixed-dose combination antibiotic incorporating ceftazidime (3rd...0 Comments 0 Shares 54 Views 0 Reviews
-
Global Doripenem Market to Reach USD 680 Million by 2034 Amid Rising Antibiotic Resistance and Hospital-Acquired InfectionsAccording to a new report from Intel Market Research, the global Doripenem market was valued at USD 450 million in 2024 and is projected to reach USD 680 million by 2034, growing at a steady CAGR of 4.1% during the forecast period (2025–2034). This growth stems from escalating antibiotic resistance and increasing prevalence of hospital-acquired infections requiring last-resort...0 Comments 0 Shares 250 Views 0 Reviews
-
Systemic Infection Treatment Market to Reach USD 22.1 Billion by 2031 | CAGR 6.4%According to a newly published market research report by 24LifeSciences, global systemic infection treatment market was valued at USD 14.3 billion in 2024 and is projected to reach USD 22.1 billion by 2031, growing at a compound annual growth rate (CAGR) of 6.4% during the forecast period 2025-2031. Systemic infection treatments combat infections that have spread throughout the bloodstream...0 Comments 0 Shares 112 Views 0 Reviews
-
Systemic Infection Treatment Market to Reach USD 22.1 Billion by 2031 | CAGR 6.4%According to a newly published market research report by 24LifeSciences, global systemic infection treatment market was valued at USD 14.3 billion in 2024 and is projected to reach USD 22.1 billion by 2031, growing at a compound annual growth rate (CAGR) of 6.4% during the forecast period 2025-2031. Systemic infection treatments combat infections that have spread throughout the bloodstream...0 Comments 0 Shares 109 Views 0 Reviews
-
Systemic Infection Treatment Market to Reach USD 22.1 Billion by 2031 | CAGR 6.4%According to a newly published market research report by 24LifeSciences, global systemic infection treatment market was valued at USD 14.3 billion in 2024 and is projected to reach USD 22.1 billion by 2031, growing at a compound annual growth rate (CAGR) of 6.4% during the forecast period 2025-2031. Systemic infection treatments combat infections that have spread throughout the bloodstream...0 Comments 0 Shares 106 Views 0 Reviews
-
Vegetable Juices Market Leaders: Growth, Share, Value, Size, and Scope"Executive Summary Animal Antimicrobials and Antibiotics Market: Share, Size & Strategic Insights The global animal antimicrobials and antibiotics market size was valued at USD 2.67 billion in 2024 and is expected to reach USD 3.80 billion by 2032, at a CAGR of 4.50% during the forecast period For an excellent outcome of Animal Antimicrobials and...0 Comments 0 Shares 2K Views 0 Reviews
More Results
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek